Cychlorphine Turns Up in L.A. County, and Test Strips Cannot Find It
The Los Angeles County Medical Examiner identified cychlorphine as the cause of a death that occurred in February, and public health officials disclosed the finding this week as the first confirmation that the synthetic opioid has reached the county's illicit drug supply. The county's Department of Public Health issued a warning to residents on October 15 describing the drug as more potent than fentanyl and undetectable by the test strips that people who use drugs have come to rely on.
The lag between the February death and the October announcement is itself part of the story, though the county did not explain the delay beyond saying the medical examiner had recently made the identification.
A molecule built to be missed
Public health officials describe cychlorphine as an opioid that behaves like fentanyl and heroin but requires far less material to stop breathing. A very small amount can cause someone to stop breathing, the county said, and the risk climbs sharply when it is taken alongside alcohol, sedatives, painkillers or other street drugs.
The drug has been found in powders, counterfeit tablets pressed to look like prescription medication, rocks or crystals, and liquids. Because it is mixed into the supply without the buyer's knowledge, a person who believes they are using one substance may be taking another at a strength they have never encountered.
Fentanyl test strips will not flag it. That matters in Los Angeles County, where strips have been distributed widely as a check against fentanyl-adulterated pills and powders. A negative strip result is not evidence that a supply is free of cychlorphine.
Nineteen states, and a Schedule I listing
Cychlorphine has been known in the U.S. illicit supply only since 2024, according to the county, and has now been detected in 19 states. In August 2026, the Drug Enforcement Administration placed it in Schedule I, making possession and sale illegal. It has never been approved by the Food and Drug Administration for any medical use.
Los Angeles County is not the first jurisdiction to record a death. In April, another fatal overdose attributed to the drug was reported in Northern California. A San Francisco teenager, 16-year-old Dante Lacourte, was identified in September as the city's first cychlorphine death, an investigation that also produced arrests. Cychlorphine sits in the same family of highly potent synthetic opioids as the nitazenes, a group that has spread through U.S. supplies with little warning to the people consuming them.
What the county is telling residents
The guidance published with the warning is the standard harm-reduction package, delivered with more urgency than usual because of the potency involved. People are urged not to use alone, to use with someone who can call 911 and administer naloxone, to start with a very small amount, and not to combine opioids with alcohol, sedatives or sleep medication.
Naloxone works against cychlorphine, and the county notes that multiple doses may be necessary. The nasal spray is available at community health stations, public health centers, retail pharmacies and through medical providers. In an emergency, officials say, call 911 and administer naloxone.
Drug checking is the other practical tool. The county points residents to a free mail-in service at drugcheckingla.com that can test samples for cychlorphine in roughly 15 to 20 minutes, a turnaround fast enough to inform a decision about the batch in hand rather than the next one.
Where someone can get help the same day
For people ready to stop, Los Angeles County maintains a filterable Services and Bed Availability Tool at SUDHelpLA.org that shows publicly funded treatment openings, including withdrawal management, residential care, intensive outpatient programs and opioid treatment programs. The RecoverLA.org platform carries the same information in a mobile format, and the county's Substance Abuse Service Helpline at 800-854-7771 connects callers directly to available beds.
Medications for opioid use disorder remain the most effective intervention for people dependent on fentanyl-era opioids, and treatment programs that prescribe buprenorphine or methadone are listed in the same county system. For readers weighing options, our guide to opioid rehab programs and what they actually provide covers levels of care and what to ask before admission.
The county said it is monitoring for changes in the prevalence of cychlorphine in the local supply. With one confirmed death and a testing system that only recently caught up to the drug, that monitoring now includes the question of how many earlier deaths in the region were never tested for it.
Sources
Editorial Board
Editorial review using SAMHSA, CDC, CMS, and state agency sources
The NWVCIL editorial team reviews and updates treatment-center information using public data from SAMHSA, CDC, CMS, and state behavioral-health agencies. We cross-check facility records, state coverage rules, and clinical-practice updates so the directory reflects current evidence and policy.
Related Articles

RTC Security Officers Carry Narcan, Saving 19 Lives in 90 Days
Security officers across Southern Nevada's transit system began carrying Narcan on July 1 and have used it in 19 overdose responses in the first 90 days.
Dane County Adds Naloxone Vending Machines in Sun Prairie and Stoughton
Dane County installed two free harm reduction vending machines stocked with naloxone in Sun Prairie and Stoughton, extending a program that had operated only in Madison.

Four Suspected Overdose Deaths in a Week Prompt Robeson County Alert
Robeson County's sheriff issued a public safety alert after four suspected overdose deaths in one week, warning that a more potent batch of fentanyl and cocaine is circulating.